These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 8616514

  • 1. Guanidine derivative U-37883A, inhibits mitochondrial K+ uniport.
    Szewczyk A, Wójcik G, Jabłonowska A, Nałecz.
    Pol J Pharmacol; 1995; 47(4):339-44. PubMed ID: 8616514
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
    Teramoto N.
    Cardiovasc Drug Rev; 2006; 24(1):25-32. PubMed ID: 16939631
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diuretic activity of N'-disubstituted morpholinoguanidine analogs of U-37883A in rats and dogs.
    Humphrey SJ, Ludens JH, Perricone SC, Skaletzky LL, Graham BE, Zins GR.
    Methods Find Exp Clin Pharmacol; 1995 May; 17(4):255-66. PubMed ID: 7475512
    [Abstract] [Full Text] [Related]

  • 8. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
    Tomoda T, Yunoki T, Naito S, Ito Y, Teramoto N.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):1-10. PubMed ID: 16242124
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
    Wellman GC, Barrett-Jolley R, Köppel H, Everitt D, Quayle JM.
    Br J Pharmacol; 1999 Oct 07; 128(4):909-16. PubMed ID: 10556925
    [Abstract] [Full Text] [Related]

  • 10. Effects of a K+ channel blocker on glomerular filtration rate and electrolyte excretion in conscious rats.
    Ludens JH, Clark MA, Lawson JA.
    J Pharmacol Exp Ther; 1995 Jun 07; 273(3):1375-81. PubMed ID: 7791110
    [Abstract] [Full Text] [Related]

  • 11. Effects of K-ATP blocking guanidine diuretics during experimental kaliuresis in rats and dogs.
    Humphrey SJ.
    Methods Find Exp Clin Pharmacol; 1995 Oct 07; 17(8):519-28. PubMed ID: 8749224
    [Abstract] [Full Text] [Related]

  • 12. Effects of U-37883A on intracellular Ca2+ -activated large-conductance K+ channels in pig proximal urethral myocytes.
    Teramoto N, Aishima M, Zhu HL, Tomoda T, Yunoki T, Takahashi-Yanaga F, Brading AF, Ito Y.
    Eur J Pharmacol; 2004 Dec 03; 506(1):1-7. PubMed ID: 15588618
    [Abstract] [Full Text] [Related]

  • 13. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
    Meisheri K, Fosset M, Humphrey S, Lazdunski M.
    Mol Pharmacol; 1995 Jan 03; 47(1):155-63. PubMed ID: 7838124
    [Abstract] [Full Text] [Related]

  • 14. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
    Ohrnberger CE, Khan SA, Meisheri KD.
    J Pharmacol Exp Ther; 1993 Oct 03; 267(1):25-30. PubMed ID: 8229751
    [Abstract] [Full Text] [Related]

  • 15. An antagonist of ATP-regulated potassium channels, the guanidine derivative U-37883A, stimulates the synthesis of phosphatidylserine in rat liver endoplasmic reticulum membranes.
    Makowski P, Szewczyk A, Jasińska R, Pikuła S.
    FEBS Lett; 1997 Jun 09; 409(2):292-6. PubMed ID: 9202164
    [Abstract] [Full Text] [Related]

  • 16. U-37883A potently inhibits dopamine-modulated K+ channels on rat striatal neurons.
    Lin YJ, Chen X, Freedman JE.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):335-41. PubMed ID: 9716371
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and diuretic activity of alkyl- and arylguanidine analogs of N,N'-dicyclohexyl-4-morpholinecarboxamidine in rats and dogs.
    Perricone SC, Humphrey SJ, Skaletzky LL, Graham BE, Zandt RA, Zins GR.
    J Med Chem; 1994 Oct 28; 37(22):3693-700. PubMed ID: 7966129
    [Abstract] [Full Text] [Related]

  • 18. Molecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A.
    Kovalev H, Quayle JM, Kamishima T, Lodwick D.
    Br J Pharmacol; 2004 Mar 28; 141(5):867-73. PubMed ID: 14757705
    [Abstract] [Full Text] [Related]

  • 19. Renal and vascular effects of chemically distinct ATP-sensitive K+ channel blockers in rats.
    Ludens JH, Clark MA, Smith MP, Humphrey SJ.
    J Cardiovasc Pharmacol; 1995 Mar 28; 25(3):404-9. PubMed ID: 7769805
    [Abstract] [Full Text] [Related]

  • 20. K-ATP-blocking diuretic PNU-37883A reduces plasma renin activity in dogs.
    Humphrey SJ, Ludens JH.
    J Cardiovasc Pharmacol; 1998 Jun 28; 31(6):894-903. PubMed ID: 9641474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.